FDA sends let­ter to No­var­tis over Kym­ri­ah man­u­fac­tur­ing safe­ty con­cerns

The FDA on Tues­day re­leased a new un­ti­tled let­ter, sent in Au­gust to No­var­tis, af­ter the agency’s in­spec­tors found new and sig­nif­i­cant is­sues with how …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.